Metropolitan Life Insurance Co. NY Buys 1,319 Shares of Utah Medical Products, Inc. (UTMD)

Metropolitan Life Insurance Co. NY boosted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 605.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,537 shares of the medical instruments supplier’s stock after buying an additional 1,319 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Utah Medical Products were worth $128,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Cardinal Capital Management raised its holdings in Utah Medical Products by 1.9% during the 4th quarter. Cardinal Capital Management now owns 10,040 shares of the medical instruments supplier’s stock valued at $834,000 after buying an additional 192 shares during the period. Rehmann Capital Advisory Group purchased a new stake in Utah Medical Products during the 4th quarter valued at $25,000. Thomson Horstmann & Bryant Inc. raised its holdings in Utah Medical Products by 0.9% during the 4th quarter. Thomson Horstmann & Bryant Inc. now owns 58,533 shares of the medical instruments supplier’s stock valued at $4,862,000 after buying an additional 511 shares during the period. New York State Common Retirement Fund raised its holdings in Utah Medical Products by 12.9% during the 4th quarter. New York State Common Retirement Fund now owns 4,517 shares of the medical instruments supplier’s stock valued at $375,000 after buying an additional 517 shares during the period. Finally, Bank of New York Mellon Corp grew its position in Utah Medical Products by 2.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 25,675 shares of the medical instruments supplier’s stock valued at $2,419,000 after acquiring an additional 605 shares during the last quarter. Institutional investors own 74.11% of the company’s stock.

In other Utah Medical Products news, Director Barbara A. Payne sold 1,525 shares of the company’s stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $85.76, for a total value of $130,784.00. Following the transaction, the director now owns 21,359 shares of the company’s stock, valued at approximately $1,831,747.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Barbara A. Payne sold 573 shares of the company’s stock in a transaction on Wednesday, February 13th. The shares were sold at an average price of $92.24, for a total value of $52,853.52. Following the completion of the transaction, the director now directly owns 23,259 shares in the company, valued at approximately $2,145,410.16. The disclosure for this sale can be found here. Insiders sold a total of 4,567 shares of company stock worth $411,477 in the last ninety days. 8.80% of the stock is currently owned by corporate insiders.

Shares of Utah Medical Products stock opened at $86.24 on Friday. The firm has a market capitalization of $320.18 million, a price-to-earnings ratio of 20.83 and a beta of 0.72. Utah Medical Products, Inc. has a 52 week low of $73.98 and a 52 week high of $117.65.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, January 31st. The medical instruments supplier reported $0.94 EPS for the quarter. The company had revenue of $9.76 million for the quarter. Utah Medical Products had a return on equity of 18.03% and a net margin of 44.18%.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 2nd. Shareholders of record on Friday, March 15th were given a $0.275 dividend. This represents a $1.10 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend was Thursday, March 14th.

Several equities analysts have commented on the company. BidaskClub raised Utah Medical Products from a “sell” rating to a “hold” rating in a research report on Wednesday, March 27th. ValuEngine downgraded Utah Medical Products from a “buy” rating to a “hold” rating in a research report on Friday, February 15th.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.thelincolnianonline.com/2019/04/21/metropolitan-life-insurance-co-ny-buys-1319-shares-of-utah-medical-products-inc-utmd.html.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Further Reading: SEC Filing

Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.